Overview

Study of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)

Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of GS-5718 in participants with Cutaneous Lupus Erythematosus (CLE) with or without Systemic Lupus Erythematosus (SLE).
Phase:
Phase 1
Details
Lead Sponsor:
Gilead Sciences